ALB and neoplasm: Two types of tumor-targeting theranostics were designed by (1) simultaneous coassembly of HSA-Ce6 and HSA-RGD forming HSA-Ce6-PTX-RGD-1 and (2) formation of HSA-Ce6@HSA-RGD core-shell structure, or HSA-Ce6-PTX-RGD-2.